Welcome to our dedicated page for Icu Medical news (Ticker: ICUI), a resource for investors and traders seeking the latest updates and insights on Icu Medical stock.
ICU Medical, Inc. (ICUI) delivers innovative infusion therapy solutions that enhance patient safety across healthcare settings. This news hub provides investors and medical professionals with timely updates on corporate developments, regulatory milestones, and clinical advancements shaping the future of drug delivery systems.
Access official press releases covering new product approvals, strategic acquisitions, and financial performance alongside analysis of market trends impacting the infusion devices sector. Our curated collection simplifies tracking ICUI's progress in developing closed-system transfer devices and smart infusion technologies that reduce healthcare-associated infections.
Discover updates on ICUI's expanding portfolio of medical consumables and monitoring systems used in critical care environments. Content spans FDA clearances, partnership announcements, and clinical study results demonstrating product efficacy. The resource serves as a comprehensive reference for understanding the company's role in advancing IV safety standards globally.
Bookmark this page for streamlined access to ICU Medical's latest developments in smart pump technology and hazardous drug handling solutions. Check regularly for verified updates about operational expansions and quality initiatives maintaining ICUI's position as an infusion therapy market leader.
ICU Medical, Inc. (Nasdaq: ICUI) has announced the schedule for its first quarter 2023 earnings release and conference call. The earnings results will be published on May 8, 2023, at approximately 4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET. Investors can access the call by dialing (877) 300-8521 and using conference ID 10177448. A live webcast of the call will also be available on the company's website, with a replay option provided afterward.
ICU Medical is recognized globally for its infusion systems and critical care products used in varied healthcare settings, underscoring its commitment to quality and innovation.
ICU Medical (Nasdaq:ICUI) announced participation in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2023, at 7:30 a.m. PT (10:30 a.m. ET). The management will engage in one-on-one meetings on the same day. Investors can access the live webcast via the company's website, with availability for replay later.
ICU Medical specializes in infusion systems and critical care products, serving hospitals and home care settings globally. The company is headquartered in San Clemente, California, focusing on quality and innovation.
FAQ
What is the current stock price of Icu Medical (ICUI)?
What is the market cap of Icu Medical (ICUI)?
